COVID-19和间歇性肺部疾病:多方面研究这两种疾病之间的关系
Jun Fukihara1, Yasuhiro Kondoh1
1Department of Respiratory Medicine and Allergy, Tosei General Hospital, 160 Nishioiwake-cho, Seto, Aichi, 489-8642, Japan.
冠状病毒疾病2019 (COVID-19) 可以导致或恶化间歇性肺部疾病 (ILD),即使它成为一种可管理的疾病. 对肺部医生来说,了解COVID-19和ILD等病毒感染之间的联系至关重要.
科学领域:
- 肺部医学 肺部医学
- 传染性疾病 传染性疾病
- 病理学 病理学 病理学
背景情况:
- 冠状病毒疾病2019 (COVID-19),由SARS-CoV-2引起,已经从致命疾病演变为可管理的疾病.
- 尽管取得了进展,但COVID-19仍然是肺部医生的担忧,因为它有可能导致肺炎,后COVID肺纤维化 (PCPF),并加剧现有的间歇性肺部疾病 (ILD).
研究的目的:
- 审查和综合有关ILDs和COVID-19之间的关系的当前知识.
- 为了阐明COVID-19诱导的ILDs的病原性.
- 检查COVID-19或抗SARS-CoV-2疫苗新引发或恶化的ILDs的临床数据.
主要方法:
- 文献综述侧重于ILDs和COVID-19之间的相互作用.
- 对用于COVID-19的ILD病变发生现有证据的分析.
- 审查过去三年的临床经验和数据.
主要成果:
- 由于COVID-19引起的ILD的发病因子尚未完全理解,但假设涉及炎症和益纤维性反应.
- 临床证据表明,COVID-19和抗SARS-CoV-2疫苗可以引发新的ILD或恶化现有的ILD.
- 在感染或接种疫苗后,炎症和菌路径与ILDs的发展或恶化有关.
结论:
- 虽然COVID-19通常是轻微的,但需要继续关注其潜在的长期肺部后果,包括ILDs.
- 需要进一步的研究,以充分理解将病毒感染,特别是COVID-19与ILDs诱导或恶化的机制.
- 病毒感染和ILD之间的关系是肺部医学正在进行的研究的一个重要领域.
更多相关视频
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
相关概念视频
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Other Pulmonary Disorders
Pneumonia II: Pathophysiology
